单抗药物专利数据集

随着生物技术的发展和人类健康需求的日益增长，新型单克隆抗体（简称"单抗")药物的研发已成为生物医药领域的重要研究方向。本数据集聚焦单抗药物产业四大细分领域，对鼠源单抗、人鼠嵌合单抗、人源化单抗、全人源化单抗专利信息进行系统搜集和加工，旨在助力政府、企业、高校及科研机构精准把握单抗药物产业技术的发展态势，为政策制定、技术研发、专利布局、市场策略及成果转化提供科学依据与决策支持，优化知识产权布局与管理策略，对推进我国单抗药物产业高质量发展。With the advancement of biotechnology and the growing demand for human health, the research and development of novel monoclonal antibody (mAb) drugs has emerged as a critical research direction in the field of biomedicine. This dataset focuses on four major sub-sectors of the mAb drug industry, and systematically collects and processes patent information pertaining to four categories of mAbs: murine monoclonal antibodies, human-mouse chimeric monoclonal antibodies, humanized monoclonal antibodies, and fully human monoclonal antibodies. It is designed to assist governments, enterprises, universities and research institutions in accurately grasping the technological development trends of the mAb drug industry, provide scientific basis and decision support for policy formulation, technological R&D, patent layout, marketing strategies and achievement transformation, optimize intellectual property (IP) layout and management strategies, and promote the high-quality development of China's mAb drug industry.

搜集汇总

背景与挑战

背景概述

该数据集是一个专注于单克隆抗体药物专利的专题集合，涵盖了鼠源单抗、人鼠嵌合单抗、人源化单抗和全人源化单抗四大技术分支，包含27208条经过系统采集、清洗和分类标引的专利记录。数据集采用高价值专利分级评价体系，旨在为政府、企业和科研机构提供产业态势分析、技术趋势识别、市场竞争评估和专利布局优化的决策支持，助力单抗药物产业的高质量发展。